Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AAPM Task Group Report 238: 3D C-arms with volumetric imaging capability.

Medical physics·2023

Same author

An interview with Dr. Edward Abrahams on companion and complementary diagnostics in the era of personalized medicine.

Expert review of molecular diagnostics·2020

Same author

Latest News & Updates from the Personalized Medicine Coalition: Letter from Washington.

Personalized medicine·2018

Same author

The Personalized Medicine Coalition - 8 months on.

Personalized medicine·2018

Same author

Letter from the President.

Personalized medicine·2018

Same author

Letter from the Executive Director.

Personalized medicine·2018

Same journal

Using a Fine-Tuned Commercial Artificial Intelligence Model to Assess Nutrients from Photographs of Japanese Meals.

Journal of diabetes science and technology·2026

Same journal

Diversity of Daily Glycemic Phenotypes Is Independently Associated With HbA1c: A Time-Resolved CGM Clustering Analysis.

Journal of diabetes science and technology·2026

Same journal

Continuous Glucose Monitoring and Early Dysglycemia: Toward an Emerging Stage Preceding Prediabetes.

Journal of diabetes science and technology·2026

Same journal

A Pilot Study on Disposal Practices and Environmental Awareness of Insulin-Related Devices Among People With Diabetes.

Journal of diabetes science and technology·2026

Same journal

Quality of In-Use Insulin Under Real-World Storage Conditions in Mwanza, Tanzania.

Journal of diabetes science and technology·2026

Same journal

Continuous Glucose Monitoring Metrics for Predicting Adverse Neonatal Outcomes in Individuals Undergoing Gestational Diabetes Screening.

Journal of diabetes science and technology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

The case for personalized medicine.

Edward Abrahams¹, Mike Silver

¹Personalized Medicine Coalition, Washington, DC 20005, USA. eabrahams@personalizedmedicinecoalition.org

Journal of Diabetes Science and Technology

|February 11, 2010

Summary

This summary is machine-generated.

Personalized medicine uses patient-specific molecular markers for more precise disease prevention and treatment. This approach offers significant value but requires overcoming adoption barriers to maximize its potential in healthcare.

More Related Videos

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Published on: September 19, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Experiment Videos

Last Updated: Jun 16, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Published on: September 19, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

Biomedical research
Genomics
Pharmacology

Background:

Traditional medicine offers a one-size-fits-all approach to disease treatment.
Advancements in molecular biology and diagnostics have enabled a more precise understanding of individual disease susceptibility and treatment response.

Purpose of the Study:

To present real-world examples demonstrating the value of personalized medicine.
To advocate for the continued growth and adoption of personalized medicine.

Main Methods:

Review of real-world case studies and clinical data.
Analysis of the impact of personalized medicine on individuals, industry, and healthcare systems.

Main Results:

Personalized medicine, utilizing genetic variation and molecular markers, enhances treatment selection and disease prediction.
Demonstrated value in improved clinical care, reduced trial durations, and cost savings.

Conclusions:

Personalized medicine is delivering significant value across healthcare.
Addressing barriers to adoption and creating incentives are crucial for its future growth and importance.